# DESCRIPTION

## TECHNICAL FIELD OF THE INVENTION

- relate to epidemiology, immunology, and molecular biology

## BACKGROUND

- introduce West Nile virus and its history

## SUMMARY OF THE INVENTION

- develop diagnostic reagents and vaccines for West Nile Virus

## BRIEF DESCRIPTION OF THE DRAWINGS

- illustrate peptide selection and scoring using EpiMatrix

## DETAILED DESCRIPTION OF THE INVENTION

- introduce West Nile Virus (WNV) and its genome
- discuss immune response to WNV, including CD4 T helper responses and dendritic cells
- describe MHC tetramers and their use in detecting immune responses to emerging viruses
- discuss the incubation period and antibody detection in WNV infection
- describe the use of tetramer technology in detecting T cell responses to WNV
- discuss the development of a preventive or therapeutic vaccine against WNV
- describe the EpiMatrix approach to epitope discovery and its application to WNV
- summarize the results of T2 B7 binding assays for WNV peptides
- discuss the potential of selected peptides for use in diagnostic assays and vaccines

### WNVX Nucleic Acids and Polypeptides

- define WNVX nucleic acid and polypeptide sequences
- describe isolated nucleic acid molecules encoding WNVX polypeptides
- explain mature forms of WNVX polypeptides
- define probes and their uses
- describe isolated nucleic acid molecules and their characteristics
- explain derivatives, homologs, and analogs of WNVX nucleic acids and polypeptides

### WNVX Nucleic Acid and Polypeptide Variants

- define WNVX nucleic acid molecules
- describe degeneracy of genetic code
- introduce conservative mutations
- discuss hybridization conditions
- summarize nucleic acid molecules encoding WNVX proteins

### WNVX Polynucleotides Encoding WNVX Candidate Peptides

- describe WNVX polynucleotides encoding vaccine candidate peptides

### Antisense Nucleic Acids

- introduce antisense nucleic acid molecules
- describe design and construction of antisense nucleic acids
- discuss administration and hybridization of antisense nucleic acids

### Ribozymes and PNA Moieties

- describe nucleic acid modifications
- introduce ribozymes and PNA moieties
- discuss applications of PNA moieties

### WNVX Polypeptides

- define WNVX polypeptides and variants
- describe production and purification of WNVX proteins

### WNVX Peptides as Antigens

- introduce WNVX peptides as antigens

### Determining Homology Between Two or More Sequences

- explain method for determining homology between sequences

### Chimeric and Fusion Proteins

- define WNVX chimeric or fusion proteins
- describe WNVX polypeptide and non-WNVX polypeptide
- illustrate fusion protein embodiments
- describe production of WNVX chimeric or fusion proteins
- outline expression vectors for fusion protein production
- motivate WNVX agonists and antagonists
- describe generation of variants of WNVX proteins
- outline screening methods for WNVX agonists and antagonists
- describe polypeptide libraries for WNVX variants
- describe monoclonal antibody production
- describe humanized antibodies
- describe fully human antibodies
- describe Fab fragments and single chain antibodies
- describe bispecific antibodies
- describe heteroconjugate antibodies
- describe effector function engineering
- summarize antibody engineering techniques
- describe chimeric and fusion proteins
- introduce immunoconjugates
- describe immunoliposomes
- outline diagnostic applications of antibodies
- discuss antibody therapeutics
- describe pharmaceutical compositions of antibodies
- outline ELISA assay
- introduce WNVX recombinant expression vectors and host cells
- define recombinant expression vectors
- describe regulatory sequences
- introduce expression vectors for prokaryotic cells
- introduce expression vectors for eukaryotic cells
- describe antisense expression vectors
- define host cells
- describe transformation and transfection techniques
- introduce methods for producing WNVX protein
- describe transgenic WNVX animals
- introduce homologous recombinant animals
- describe pharmaceutical compositions
- describe pharmaceutical compositions
- outline administration methods
- discuss gene therapy vectors
- describe vaccine composition
- outline antigen carrier systems
- introduce screening and detection methods
- describe screening assays
- introduce chimeric and fusion proteins
- describe cell-based assays
- describe cell-free assays
- describe immobilization of proteins on matrices
- identify modulators of WNVX protein expression
- describe two-hybrid assay or three hybrid assay
- introduce detection assays
- describe predictive medicine
- describe diagnostic assays
- describe kits for detecting WNVX
- introduce prognostic assays
- describe methods for identifying subjects susceptible to WNVX infection
- outline methods for detecting genetic lesions in WNVX gene
- describe alternative amplification methods
- outline methods for detecting mutations in WNVX gene
- describe pharmacogenomics
- outline importance of pharmacogenomics in selecting effective agents
- describe monitoring of effects during clinical trials
- outline methods for monitoring effectiveness of treatment
- describe use of gene expression patterns as markers of physiological response
- outline method for altering administration of agent based on monitoring results
- introduce methods of treatment
- describe diseases and disorders
- outline prophylactic methods
- outline therapeutic methods
- describe method of administration
- determine biological effect of therapeutic

## EXAMPLES

### Example 1

- obtain WNV sequence and parse into overlapping peptides

### Example 2

- describe EpiMatrix analysis
- apply EpiMatrix to screen WNV peptides for HLA B*07 binding

### Example 3

- analyze overall scores of WNV peptides
- compare scores to random set and known HLA B*07 binders

### Example 4

- select peptides for in vitro screening based on EpiMatrix scores

### Example 5

- analyze cross-reactivity of selected peptides with other flaviviruses

### Example 6

- synthesize peptides for in vitro binding studies

### Example 7

- perform MHC binding studies using T2B7 binding assay

### Other Embodiments

- discuss variations and modifications of the invention

